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Summary
Peptide hormones such as parathyroid hormone (PTH) are
processed after translation through steps that are critical for
their proper folding, secretion and activity. This mini-review
will briefly summarize the known mutations of the pre-
proparathyroid hormone gene that  are known to interfere with
proper processing of PTH and are a cause of primary hy-
poparathyroidism. 
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Parathyroid hormone (PTH), one of the major regulators of cal-
cium and phosphate homeostasis, is synthesized by the
parathyroid glands as a larger precursor, pre-proparathyroid
hormone (preproPTH) (1). The preproPTH is first cleaved to
proPTH and then to PTH. The preproPTH has 25-residue “pre”
or signal sequence and a 6-residue “pro” sequence. The signal
sequence, along with the short “pro” sequence, has the func-
tion to direct the protein into the secretory pathway. During
transit across the membrane of the endoplasmic reticulum, the
signal sequence is cleaved off and rapidly degraded. Like most
other signal sequences found at the beginning of precursors of
secreted proteins, the signal sequence of preproPTH contains
an interrupted stretch of hydrophobic and non-polar amino
acids. The importance of the signal sequence for normal secre-
tion of PTH is illustrated by the hypoparathyroidism inherited in
families carrying mutations in the signal sequence of pre-
proPTH (see below). Conversely, the role of the short “pro” se-
quence is not completely understood; however, experimental
evidence strongly suggest that the prohormonal hexapeptide
sequence of preproPTH functions to optimize the efficiency
and accuracy of signal-sequence cleavage (2). After cleavage
of the “pro” sequence, the mature PTH 1-84 is accumulated
and stored into secretory granules. 
Idiopathic hypoparathyroidism is a heterogenous group of
metabolic disorders characterized by hypocalcaemia and hy-
pophosphatemia due to deficient secretion of PTH, and not
secondary to surgery or other acquired disorders (3). Idiopathic
hypoparathyroidism can be either familial or sporadic. Sporadic
idiopathic hypoparathyroidism is more frequent. Familial idio-
pathic hypoparathyroidism can be part of a complex autoim-
mune disorder or occur as an isolated entity. This form of the
disorder is called “familial isolated hypoparathyroidism” (FIH)
(3). This review will briefly discuss the cases of FIH due to mu-
tations in the preproPTH sequence. 
The human PTH gene contains 3 exons that are located on the
short arm of chromosome 11 (4). Exon 1 contains the untrans-
lated region. Exon 2 encodes the signal peptide and part of the
prohormone sequence. Exon 3 encodes the rest of the prohor-
mone sequence, the 84-aminoacid peptide, and the 3’-untrans-
lated region (4). 
The first indication that the preproPTH sequence could be as-
sociated to FIH was a study by Ahn and colleagues in which in
2 out of 8 families with FIH concordance was identified be-
tween the inheritance of hypoparathyroidism and specific PTH
alleles in affected members. In particular, in one family, for
which inheritance of FIH was consistent with the presence of
hypoparathyroidism, evidence for linkage analysis was suffi-
ciently strong (LOD score 1.505) (3). Arnold and colleagues
pursued this interesting finding, and they cloned and analyzed
the putatively abnormal preproPTH gene and the putative wild-
type allele from an affected member of this last family (5). A
single point mutation (T to C transition) in exon2 that resulted
in substitution of cysteine with an arginine at position 18 of the
signal sequence was identified in the putatively abnormal gene,
and not in the normal one (Figure 1). The presence of this sin-
gle point mutation was confirmed in affected family members
and excluded in the others. Detailed and elegant analysis of
the biological consequences of this missense mutation by
Karaplis and colleagues provided clear evidence that the muta-
tion was associated with deleterious effects on the processing
f preproPTH to proPTH (6). 
Thakker and colleagues investigated one kindred with autoso-
mal recessive FIH, and identified a G to C substitution in the
first nucleotide of intron 2 of the PTH gene, generating a donor
splice mutation (7). This study revealed that the patients were
homozygous for the mutant alleles, while the unaffected rela-
tiv s were heterozygous, and unrelated normals were homozy-
gous for the wild type alleles. The mutation resulted in exon
skipping with a loss of exon 2, which encodes the initiation
codon and the signal peptide, thereby causing PTH deficiency
(7).
In 1999, a novel mutation of the signal peptide of the pre-
proPTH gene associated with autosomal recessive FIH was
described (8). A replacement of T to C was found in the first
nucleotide of position 23 in the 25-amino acid signal peptide
(Figure 1). This resulted in the replacement of the normal ser-
in  with a proline. Affected family members were homozygous
for the mutation, whereas the parents were heterozygous, sup-
porting autosomal recessive inheritance. As this mutation is
very close to the cleavage site, it is likely that the preproPTH
mutant may not be cleaved by signal peptidase at the normal
position, and it might be degraded in rough endoplasmic reticu-
lum. 
Taken together, mutations in the PTH gene have been report-
ed in three families with FIH. The first family had mutation in
the hydrophobic core of the signal peptide, producing the auto-
s mal dominant form of FIH. The second family had a mutation
n the exon2-intron2 junction that skipped the next exon and
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produced the autosomal recessive form of FIH. The third family
had a new autosomal recessive form of FIH with a point muta-
tion in the signal peptide that leads to the amino acid substitu-
tion serine 23 to proline at position.
Further studies are now required to elucidate whether genes
coding for other molecules, such as calcium sensing receptor
are indeed involved in additional cases of FIH for which the ge-
netic defect has not been yet identified (9).
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Figure 1 - Human signal sequence and “pro” sequence of human pre-
proPTH.Missense mutations identified inFIH are shown.
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